KEB Asset Management’s Eli Lilly LLY Stock Holding History

KEB Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$571K	Sell	476 -3	-0.6%	-$3.06K	0.09%	61
2026 Q1	$441K	Buy	479 +20	+4%	+$20.3K	0.08%	66
2025 Q4	$493K	Sell	459 -24	-5%	-$22.9K	0.1%	64
2025 Q3	$369K	Buy	483 +2	+0.4%	+$1.49K	0.08%	70
2025 Q2	$375K	Hold	481	–	–	0.09%	66
2025 Q1	$397K	Sell	481 -50	-9%	-$41.6K	0.11%	54
2024 Q4	$410K	Sell	531 -469	-47%	-$388K	0.12%	52
2024 Q3	$886K	Buy	1,000 +150	+18%	+$135K	0.27%	36
2024 Q2	$770K	Buy	850 +350	+70%	+$280K	0.26%	34
2024 Q1	$389K	Hold	500	–	–	0.13%	46
2023 Q4	$291K	Hold	500	–	–	0.11%	54
2023 Q3	$269K	Hold	500	–	–	0.11%	50
2023 Q2	$234K	Buy	+500	New	+$210K	0.1%	52

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KEB Asset Management's LLY Position: Q2 2026 in Review

KEB Asset Management reduced its Eli Lilly (LLY) stake by 0.63% in Q2 2026, selling an estimated $3.06K and leaving 476 shares worth $571K. The position accounts for 0.09% of the portfolio, ranked #61.

KEB Asset Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $886K in Q3 2024. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

KEB Asset Management held 476 shares of Eli Lilly worth $571K as of Q2 2026.
KEB Asset Management sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
Eli Lilly made up 0.09% of KEB Asset Management's portfolio in Q2 2026, its #61 holding.
KEB Asset Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
KEB Asset Management's Eli Lilly position peaked at $886K in Q3 2024.
4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KEB Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.